NCI Dictionary of Cancer Terms
eribulin mesylate (er-eh-BYOO-lin MEH-zih-layt)
A drug used to treat metastatic breast cancer in patients who have already been treated with other chemotherapy. It is also being studied in the treatment of other types of cancer. Eribulin mesylate may block cancer cell growth by stopping cell division. It belongs to the family of drugs called antitubulin agents. Also called E7389 and Halaven.